A Day Up For Xenetic Biosciences, Inc.
Wed, Oct 08, 2025 at 07:54 PM
Xenetic Biosciences, Inc. (XBIO:NASDAQ) jumped higher at $10.36, representing a gain of 141.5%. On Wed, Oct 08, 2025, XBIO:NASDAQ touched a New 2-Week High of $10.36. From Wed, Sep 24, 2025, the stock recorded 40.00% Up Days and 54.55% Green Days
The stock spiked on Wed, Oct 08, 2025 at $13.93 with a volume of 47M+.
About Xenetic Biosciences, Inc. (XBIO:NASDAQ)
Xenetic Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics.
Top 10 Gainers:
- Xenetic Biosciences, Inc. (XBIO:NASDAQ), 141.49%
- Nexalin Technology, Inc. (NXL:NASDAQ), 98.25%
- AlphaTON Capital Corp Shs (New) (ATON:NASDAQ), 95.52%
- Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 89.25%
- Universe Pharmaceuticals INC (UPC:NASDAQ), 82.98%
- Adaptimmune Therapeutics plc (ADAP:NASDAQ), 51.88%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 46.43%
- TNL Mediagene (TNMG:NASDAQ), 45.5%
- Soluna Holdings, Inc. (SLNH:NASDAQ), 39.41%